Nucleome Therapeutics Limited OXFORD


Nucleome Therapeutics Limited is a private limited company that can be found at Suite C, Second Floor, Schrodinger Building,, Oxford Science Park, Oxford OX4 4GE. Incorporated on 2019-07-17, this 4-year-old company is run by 8 directors and 1 secretary.
Director Russell G., appointed on 06 September 2023. Director Emma J., appointed on 02 March 2023. Director Bauke A., appointed on 21 October 2022.
Moving on to secretaries, we can name: Phil B., appointed on 21 October 2022.
The company is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110).
The last confirmation statement was sent on 2023-08-07 and the deadline for the subsequent filing is 2024-08-21. Furthermore, the annual accounts were filed on 31 July 2022 and the next filing is due on 30 April 2024.

Nucleome Therapeutics Limited Address / Contact

Office Address Suite C, Second Floor, Schrodinger Building,
Office Address2 Oxford Science Park
Town Oxford
Post code OX4 4GE
Country of origin United Kingdom

Company Information / Profile

Registration Number 12109297
Date of Incorporation Wed, 17th Jul 2019
Industry Research and experimental development on biotechnology
End of financial Year 31st July
Company age 5 years old
Account next due date Tue, 30th Apr 2024 (1 day left)
Account last made up date Sun, 31st Jul 2022
Next confirmation statement due date Wed, 21st Aug 2024 (2024-08-21)
Last confirmation statement dated Mon, 7th Aug 2023

Company staff

Russell G.

Position: Director

Appointed: 06 September 2023

Emma J.

Position: Director

Appointed: 02 March 2023

Bauke A.

Position: Director

Appointed: 21 October 2022

Fiona M.

Position: Director

Appointed: 21 October 2022

Phil B.

Position: Secretary

Appointed: 21 October 2022

Rana A.

Position: Director

Appointed: 21 October 2022

Jonathan H.

Position: Director

Appointed: 30 November 2020

Danuta J.

Position: Director

Appointed: 02 August 2019

James H.

Position: Director

Appointed: 17 July 2019

Lachlan M.

Position: Director

Appointed: 02 August 2019

Resigned: 16 October 2020

People with significant control

The register of PSCs who own or control the company includes 2 names. As we found, there is Oxford Science Enterprises Plc from Oxford, United Kingdom. This PSC is categorised as "a corporate", has 25-50% voting rights. This PSC has 25-50% voting rights. The second one in the persons with significant control register is James H. This PSC owns 75,01-100% shares and has 75,01-100% voting rights.

Oxford Science Enterprises Plc

46 Woodstock Road, Oxford, OX2 6HT, United Kingdom

Legal authority Companies Act 2006
Legal form Corporate
Country registered England And Wales
Place registered Companies House
Registration number 09093331
Notified on 2 August 2019
Nature of control: 25-50% voting rights

James H.

Notified on 17 July 2019
Ceased on 29 July 2019
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Company filings

Filing category
Accounts Address Capital Confirmation statement Incorporation Officers Persons with significant control Resolution
Change to a person with significant control Saturday 26th August 2023
filed on: 20th, February 2024
Free Download (2 pages)

Company search